The MARCE supports a two-site Non-Human Primates Core Facility (“NHP Core”) at the University of Maryland, Baltimore and the University of Pittsburgh’s Regional Biocontainment Laboratory (RBL). Optimal utilization of non-human primates for biodefense and emerging infectious disease research requires a facility whereby animals are housed in appropriate biocontainment (animal biosafety levels 2 and 3), and research personnel experienced in the methodologies required for infectious disease research and vaccine development.